GlassScriptPhysician profile
Paul Guske
NPI 1952361511
$30,666.30
in general payments reported to CMS, 2019-2025
36 companies · $2,686 in 2025
The $2,686 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $17K · 2021: $6,532 · 2022: $873 · 2023: $1,664 · 2024: $471 · 2025: $2,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,422 · Travel and Lodging: $2,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,421.69 |
| Travel and Lodging | $2,399.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,249.39 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,543.99 | 2025 | Linx Reflux Management System |
| Endo Pharmaceuticals INC. | $575.95 | 2019-2023 | Nascobal |
| Medtronic, INC. | $453.29 | 2021-2025 | Signia, Nim Vital, Maxtack |
| Integra Lifesciences Corporation | $337.49 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Novo Nordisk INC | $308.79 | 2020-2025 | Wegovy |
| Smith+Nephew, INC. | $226.24 | 2020-2025 | Stravix, Grafix Pl, Pico 14 |
| Pacira Pharmaceuticals Incorporated | $221.30 | 2023-2025 | Exparel |
| Ethicon US, LLC | $207.15 | 2019-2025 | Harmonic, Linx Reflux Management System, Surgicel Nu-Knit |
| Hologic Sales and Service, LLC | $141.31 | 2024 | Coolseal Generator |
| Tela Bio, INC. | $124.97 | 2022-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $116.69 | 2023 | Tisseel |
| Davol INC. | $115.92 | 2019-2021 | |
| Stryker Corporation | $110.06 | 2019 | |
| Heron Therapeutics, INC. | $101.52 | 2021-2025 | Zynrelef |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $96.09 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.16 | 2021-2023 | Gattex |
| Covidien LP | $75.28 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $73.31 | 2024 | Gore Synecor Biomaterial, Seamguard Staple Line Reinforcement, Gore Enform Preperitoneal Biomaterial |
| Lexington Medical, INC. | $69.25 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $65.56 | 2022-2023 | Seglentis |
| Innocoll Pharmaceuticals Limited | $65.55 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $47.69 | 2023-2024 | |
| Mimedx Group, INC. | $36.44 | 2025 | |
| Braintree Laboratories, INC. | $31.76 | 2021-2025 | Sutab, Suflave |
| Innovation Technologies INC | $22.41 | 2022 | |
| Tei Biosciences INC | $22.38 | 2019 | |
| Kci USA, INC. | $21.40 | 2021 | |
| Palette Life Sciences, INC. | $18.94 | 2021 | |
| Lilly USA, LLC | $18.14 | 2024 | Zepbound |
| Shire North American Group INC | $15.37 | 2019 | |
| Olympus America INC. | $15.31 | 2025 | Gastrointestinal Videoscope, Visera Elite Video System Center, Evis Exera III Colonovideoscope |
| Focal Therapeutics, INC. | $14.48 | 2020 | |
| Baudax Bio INC. | $14.34 | 2022 | |
| Acera Surgical, INC. | $14.10 | 2025 | Restrata Wound Matrix |
| Acell, INC. | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Guske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.